Gen Re’s partnership with Monsenso allows insurers to offer mental health solutions
Danish technology company Monsenso, which develops mHealth solutions for mental health, has partnered with Gen Re.
The objective of the partnership is to help insurance companies take advantage of Monsenso’s mHealth solution, which can assist in the prevention, early intervention and treatment of mental illness.
The Monsenso mHealth solution provides care to people with behavioural disorders, and the provider says its solution has the potential to improve the prevention and management of disability claims.
With its mHealth solution, Monsenso said individuals can self-monitor their lifestyle and their symptoms, helping them recover faster from mental illness.
Gen Re and Monsenso will work together to help insurance companies offer an enhanced service to their customers, and reduce costs in the process. By offering the solution, insurers can actively help their customers return to work more quickly, and avoid becoming ill again
Thomas Lethenborg, CEO at Monsenso, said, “The objective of this partnership is to promote the use of mHealth technology among insurance companies. With this technology, their customers can get better faster by receiving better mental health care, while reducing costs at the same time.”
He added: “Monsenso is looking to build sustainable, long-term partnerships, with the ultimate goal of delivering better care, to more people, at a lower cost.”
Jules Constantinou, regional manager, Gen Re Life/Health UK & Ireland, said: “ It is important that the life insurance industry embrace new technologies and new processes in order to remain relevant in the lives of customers going forward.
“Clinical medicine is also evolving and we are very pleased to announce this partnership with Monsenso, which should improve outcomes for insurance claimants who are battling mental illness”.
With its origins at the IT University of Copenhagen, the Monsenso mHealth solution for mental illnesses holds a CE Mark and a TGA certification.
Monsenso said it is currently being used in a clinical capacity in the UK, Denmark, Norway, Sweden, Germany and Australia to support the treatment of a wide range of mental and behavioural disorders.
Gen Re delivers reinsurance solutions to the life/health and property/casualty insurance industries. With $14bn in capital and approx. $6bn in premiums, it is one of the leading reinsurers in the world.
For all the latest insight, news and data on the global life and health insurance and reinsurance markets, visit www.lifeinsuranceinternational.com